Journal of Japanese Society of Oral Oncology
Online ISSN : 1884-4995
Print ISSN : 0915-5988
ISSN-L : 0915-5988
Volume 19, Issue 3
Displaying 1-3 of 3 articles from this issue
  • [in Japanese], [in Japanese]
    2007 Volume 19 Issue 3 Pages 139-161
    Published: September 15, 2007
    Released on J-STAGE: May 31, 2010
    JOURNAL FREE ACCESS
    Download PDF (16699K)
  • Akiyuki Maeda, Satoru Ozeki, Eiichiro Ariji, Toshiyuki Izumo, Hiroshi ...
    2007 Volume 19 Issue 3 Pages 163-175
    Published: September 15, 2007
    Released on J-STAGE: May 31, 2010
    JOURNAL FREE ACCESS
    As the first step of making a guideline of the treatment for tongue cancer, a questionnaire survey had been made in order to obtain a present status of the treatment in Japan. The results and controversial issues of 75 respondents are reported.
    Total 5, 960 cases of tongue cancer were treated in the 75 institutions in the past 10 years (1995-2004) . T2 cases amounted to 45.7% of them (2, 700 cases) and N0 to 73.9% (4, 360) .
    In surgical treatments, as the indication to methods of glossectomy, neck dissection for cervical lymph node metastasis and reconstruction of the tongue was almost common in each institution, making of the standardized guideline for surgical treatment seems to be possible.
    On the other hand, the purpose and practical criteria of the indication for the pre- and postoperative chemoradiotherapy vary considerably in each institution. Thus, the standardization of the criteria of the indication for adjuvant chemoradiotherapy is mandatory and it seems to be the difficult task in making the guideline. In any case, the guideline must include treatments with high quality of evidence.
    Download PDF (1617K)
  • Masahiro Umeda, Yasutaka Ojima, Hideki Komatsubara, Takashi Shigeta, T ...
    2007 Volume 19 Issue 3 Pages 177-181
    Published: September 15, 2007
    Released on J-STAGE: May 31, 2010
    JOURNAL FREE ACCESS
    Two cases with tongue cancer who died of interstitial pneumonia probably caused by peplomycin (PEP) are presented. Case 1 was a 58-year-old male with carcinoma of the tongue. He had a past history of carcinoma of the buccal mucosa 7 years before the first visit, which was treated by chemotherapy with PEP (40mg), radiotherapy and laser surgery. He underwent chemotherapy with PEP again (25mg), followed by radical operation. Immediately after surgery, interstitial pneumonia occurred and he died 48 days after the operation. Case 2 was a 71-year-old female with carcinoma of the tongue. She underwent partial glossectomy, but 13 months later late neck metastasis appeared. She underwent induction chemotherapy with CDDP, 5FU and PEP (25mg), and neck dissection was scheduled. However, interstitial pneumonia occurred, and she died 17 days after the chemotherapy. Great caution seems to be necessary for the occurrence of interstitial pneumonia even if the patient is not so old and the total dose of PEP is not high.
    Download PDF (5183K)
feedback
Top